LenioBio logo — Rapid eukaryotic, cell-free protein expression that scales f...

LenioBio

Rapid eukaryotic, cell-free protein expression that scales for research, development and production.

Founded 2016 Germany Dusseldorf, Germany 49 employees Grant Total: $14.25M Biotechnology

General Information

Company Name LenioBio
Founded Year 2016
Location Germany Dusseldorf, Germany +2
Employees 49
Industries Biotechnology
Funding Stage Grant
Social

Get notified when LenioBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LenioBio

LenioBio, a biotechnology startup headquartered in Germany, was founded in 2016. The company's mission is to revolutionize the production of medicines and food by developing efficient, robust, and sustainable technologies. LenioBio specializes in rapid eukaryotic, cell-free protein expression that scales for research, development, and production. Their approach, unconstrained by the limitations of cells, involves combining proprietary protein technology with machine learning to accelerate innovation cycles in the life science industry. The startup recently secured a grant investment from EIT Food on 14 September 2023. This funding is expected to bolster LenioBio's efforts in disrupting the traditional methods of producing essential pharmaceuticals and food products. With its innovative approach and recent financial backing, LenioBio is well-positioned to make significant strides in the biotechnology sector, potentially reshaping the future of protein expression technologies for varied applications.

Taxonomy: Protein Expression, Protein Production, Synthetic Biology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Plant-based protein, Innovation Cycles

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
14 Sep 2023
Grant •••••• 1 •••• •••• 09 May 2022
Series A •••••• 1 •••• •••• 06 Mar 2022

LenioBio Alternatives & Competitors

LenioBio vs
U-Protein Express BV
U-Protein Express BV The Netherlands

U-Protein Express BV was acquired by ImmunoPrecise Antibodies Ltd.. Visit www.ImmunoPrecise.com for...

8 employees
Biotechnology
LenioBio vs

Curing the food system one protein at a time. 1st product is a sugar substitute that is a sustainab...

Series Unknown
49 employees
Biotechnology, Food and Beverage
LenioBio vs

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects !

Series Unknown
10 employees
Biotechnology, Health Care
Also compare with: LenioBio vs SynHelix SynHelix

FAQ About LenioBio

Rapid eukaryotic, cell-free protein expression that scales for research, development and production.
LenioBio was founded in 2016.
LenioBio is headquartered in Dusseldorf, Germany.
LenioBio operates in the following industries: Biotechnology.
LenioBio has approximately 49 employees.
LenioBio has completed 3 funding rounds, raising a total of $14.25M. The latest funding stage is Grant.
Top alternatives and competitors to LenioBio include U-Protein Express BV, Amai Proteins, SYNTHELIS, SynHelix, Creative Biostructure. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LenioBio and U-Protein Express BV are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LenioBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy